Japanese Generic Drug Maker Towa Invests ¥20 Billion To Increase Capacity
This article was originally published in PharmAsia News
Executive Summary
Major Japanese generic drug maker Towa Pharmaceutical will invest ¥20 billion to build a new factory in Yamagata Prefecture. To be completed in 2012, the new facility will have an annual production capacity of 7.5 billion tablets and 50 million injections, which is 1.5 times larger than its current site. Towa expects further expansion in the Japanese generic drug market due to the national policy of restraining medical costs.(Click here for more - Japanese language